At close: November 19 at 2:08 PM GMT+1
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jesper Birgemo | Chief Executive Officer | -- | -- | 1977 |
Bio Vitos Pharma AB (publ)
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 1
Description
Bio Vitos Pharma AB (publ) operates as a medical technology company in Sweden and internationally. The company develops and commercializes Helge, which detects hemolysis in vacuum tubes and blood gas samples. It serves emergency departments in the European Union and the United States. It has a collaboration agreement with KFUM Kalmar to conduct a research study. The company was formerly known as Hemcheck Sweden AB (publ) and changed its name to Bio Vitos Pharma AB (publ) in December 2023. Bio Vitos Pharma AB (publ) was incorporated in 2010 and is based in Solna, Sweden.
Corporate Governance
Bio Vitos Pharma AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
BICO.ST BICO Group AB (publ)
34.02
-1.85%
TBIO Telesis Bio, Inc.
0.9500
+3.26%
VERO Venus Concept Inc.
0.3120
-0.64%
BJDX Bluejay Diagnostics, Inc.
3.2400
-10.87%
TNON Tenon Medical, Inc.
2.5400
+2.01%
NUWE Nuwellis, Inc.
1.3400
-0.74%
SINT Sintx Technologies, Inc.
3.2500
+2.20%
PACB Pacific Biosciences of California, Inc.
1.7200
+9.55%
DXCM DexCom, Inc.
74.88
-1.82%